Trial Profile
Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone Quadrivalent (Influenza Vaccine) Among Healthy Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 26 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Sep 2015 New trial record